2019 Health Trends data now available!
An interactive state-by-state overview of patient compliance and inconsistent results
Select the state to download an overview of an individual state’s opioid prescription guidelines
Use of so-called “full-spectrum” formulations of cannabidiol (CBD) products can cause users to test positive for THC, the component of marijuana that causes euphoria, according to an open-label study published in JAMA Psychiatry.
Full-spectrum CBD products contain THC, but at levels too low (≤0.30% by weight) to meet federal guidelines…More stories